Desuden reducerer ZOSTAVAX betydeligt zosterassocierede smerter som målt ved sygdomsbyrdescoren (BOI (Burden of Illness)) for HZ- smerter (se resultater og definitioner i tabel 1).
In addition, ZOSTAVAX significantly reduced zoster-associated pain as measured by the HZ pain Burden of Illness (BOI) score (see results and definition in Table 1).